SGP
SpyGlass Pharma, Inc.
34.97
+0.79 (+2.31%)
52w low 17.06
39.92 high
78.3% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -- | -6.33M | -8.84M | -9.33M | -13.54M | -14.84M | |
| Depreciation & Amort | -- | 134.00K | 137.27K | 216.73K | 318.00K | 342.00K | |
| Capital Expenditure | -- | -52.00K | -152.51K | -420.49K | -676.00K | -1.93M | |
| Free Cash Flow | -- | -6.38M | -8.99M | -9.75M | -14.22M | -16.77M | |
| Investing Cash Flow | -- | -52.00K | -12.15M | 574.70K | -1.67M | -933.00K | |
| Financing Cash Flow | -- | 75.61M | -234.36K | -889.64K | 157.75M | 13.00K | |
| Share Buybacks | -- | -- | 0.00 | 0.00 | -- | -- |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--